KIORA PHARMACEUTICALS, INC. (KPRX) Return on equity 2018–2025
KIORA PHARMACEUTICALS, INC. (KPRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-67.2%FY2025 · since FY2018: -121.0% → -67.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -67.2% | -81.1 pp |
| FY2024 | 14.0% | +218.8 pp |
| FY2023 | -204.8% | — |
| FY2021 | -94.5% | -23.9 pp |
| FY2020 | -70.5% | +36.6 pp |
| FY2019 | -107.2% | +13.8 pp |
| FY2018 | -121.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More KPRX financial trends
KPRX RevenueKPRX Net incomeKPRX Net marginKPRX Gross profitKPRX Gross marginKPRX Operating incomeKPRX Operating marginKPRX Operating cash flowKPRX Free cash flowKPRX Capital expendituresKPRX Stock buybacksKPRX Dividends paidKPRX Total assetsKPRX Total liabilitiesKPRX Shareholders’ equityKPRX overview →